Cyanidin-3-rutinoside, a natural polyphenol antioxidant, selectively kills leukemic cells by induction of oxidative stress

被引:164
作者
Feng, Rentian
Ni, Hong-Min
Wang, Shiow Y.
Tourkova, Irina L.
Shurin, Michael R.
Harada, Hisashi
Yin, Xiao-Ming
机构
[1] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA
[2] USDA ARS, Beltsville Agr Res Ctr, Fruit Lab, Beltsville, MD 20705 USA
[3] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23298 USA
关键词
D O I
10.1074/jbc.M610616200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Anthocyanins are a group of naturally occurring phenolic compounds widely available in fruits and vegetables in human diets. They have broad biological activities including anti-mutagenesis and anticarcinogenesis, which are generally attributed to their antioxidant activities. We studied the effects and the mechanisms of the most common type of anthocyanins, cyanidin-3-rutinoside, in several leukemia and lymphoma cell lines. We found that cyanidin-3-rutinoside extracted and purified from the black raspberry cultivar Jewel induced apoptosis in HL-60 cells in a dose-and time-dependent manner. Paradoxically, this compound induced the accumulation of peroxides, which are involved in the induction of apoptosis in HL-60 cells. In addition, cyanidin-3-rutinoside treatment resulted in reactive oxygen species (ROS)-dependent activation of p38 MAPK and JNK, which contributed to cell death by activating the mitochondrial pathway mediated by Bim. Down-regulation of Bim or overexpression of Bcl-2 or Bcl-x(L) considerably blocked apoptosis. Notably, cyanidin-3-rutinoside treatment did not lead to increased ROS accumulation in normal human peripheral blood mononuclear cells and had no cytotoxic effects on these cells. These results indicate that cyanidin-3-rutinoside has the potential to be used in leukemia therapy with the advantages of being widely available and selective against tumors.
引用
收藏
页码:13468 / 13476
页数:9
相关论文
共 43 条
[1]   Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome c and activation of caspase-3 [J].
Amarante-Mendes, GP ;
Kim, CN ;
Liu, L ;
Huang, Y ;
Perkins, CL ;
Green, DR ;
Bhalla, K .
BLOOD, 1998, 91 (05) :1700-1705
[2]   p38 MAP kinase mediates apoptosis through phosphorylation of BimEL at Ser-65 [J].
Cai, Beibei ;
Chang, Sandra H. ;
Becker, Esther B. E. ;
Bonni, Azad ;
Xia, Zhengui .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (35) :25215-25222
[3]   PROOXIDANT STATES AND TUMOR PROMOTION [J].
CERUTTI, PA .
SCIENCE, 1985, 227 (4685) :375-381
[4]   Caspase cleavage of BiMEL triggers a positive feedback amplification of apoptotic signaling [J].
Chen, D ;
Zhou, Q .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (05) :1235-1240
[5]  
Davies KJA, 1999, IUBMB LIFE, V48, P41, DOI 10.1080/152165499307404
[6]   Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity [J].
Ding, Min ;
Feng, Rentian ;
Wang, Shiow Y. ;
Bowman, Linda ;
Lu, Yongju ;
Qian, Yong ;
Castranova, Vincent ;
Jiang, Bing-Hua ;
Shi, Xianglin .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (25) :17359-17368
[7]   Bid-dependent generation of oxygen radicals promotes death receptor activation-induced apoptosis in murine hepatocytes [J].
Ding, WX ;
Ni, HM ;
DiFrancesca, D ;
Stolz, DB ;
Yin, XM .
HEPATOLOGY, 2004, 40 (02) :403-413
[8]   Blackberry extracts inhibit activating protein 1 activation and cell transformation by perturbing the mitogenic signaling pathway [J].
Feng, R ;
Bowman, LL ;
Lu, YJ ;
Leonard, SS ;
Shi, XL ;
Jiang, BH ;
Castranova, V ;
Vallyathan, V ;
Ding, M .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2004, 50 (01) :80-89
[9]   Inhibition of activator protein-1, NF-κB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid [J].
Feng, RT ;
Lu, YJ ;
Bowman, LL ;
Qian, Y ;
Castranova, V ;
Ding, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (30) :27888-27895
[10]   In vitro antitumor activity of cyanidin-3-O-β-glucopyranoside [J].
Fimognari, C ;
Berti, F ;
Nüsse, M ;
Forti, GC ;
Hrelia, P .
CHEMOTHERAPY, 2005, 51 (06) :332-335